Live Breaking News & Updates on Raises full year revenue guidance

Stay updated with breaking news from Raises full year revenue guidance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Eli Lilly and : Q1 Earnings 2024 Press Release

April 30, 2024

For Release: Immediately

Refer to: Jordan Bishop; jordan.bishop@lilly.com; 473-5712 Joe Fletcher;...

Indianapolis , Indiana , United-states , Germany , Jordan , United-kingdom , Eli-lilly , Davida-ricks , Joe-fletcher , Drug-administration , Nexus-pharmaceuticals , Advisory-committee

Lebrikizumab for Atopic Dermatitis Resubmitted for FDA Approval After Previous Rejection

The decision by Eli Lilly to resubmit lebrikizumab to the FDA for adults and adolescents with eczema is expected to receive a response in the second half of the year.

United-kingdom , Japan , Eli-lilly , Facebook , Drug-administration , European-union , Reports-first-quarter , Raises-full-year-revenue-guidance , Highlights-pipeline , Complete-response-letter , Lebrikizumab-treatment , Atopic-dermatitis

FTSE 100 Rises As Banks, Miners and Oil Majors Gain

FTSE 100 Rises As Banks, Miners and Oil Majors Gain
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

China , Israel , Israeli , Ben-jerry , Sathishb-sivakumar , Michel-demare , Aston-martin , Robin-speakman , Nostrum-oil-gas , Croda-international , Jupiter-fund-management , Glencore